INR 19.07
(0.37%)
Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Revenue | 3.38 Million | 3.32 Million | 570 Thousand | 1.69 Million | 4 Million |
Cost of Revenue | 547 Thousand | 614 Thousand | 456 Thousand | 450 Thousand | - |
Gross Profit | 2.83 Million | 2.7 Million | 114 Thousand | 1.24 Million | 4 Million |
Operating Expenses | 2.83 Million | 1.91 Million | 2.14 Million | 3.5 Million | 2.23 Million |
Selling, General and Administrative Expenses | 1.03 Million | 1.53 Million | 1.8 Million | 3.2 Million | 1.63 Million |
Research and Development Expenses | - | - | - | - | - |
Other Expenses | 1.8 Million | - | 1000.00 | 2000.00 | 594 Thousand |
Cost and Expenses | 3.38 Million | 2.53 Million | 2.6 Million | 3.95 Million | 2.23 Million |
Operating Income | - | 482 Thousand | -2.28 Million | 4.18 Million | -2.23 Million |
Interest Expense | - | 2000.00 | 1000.00 | - | - |
Income Tax Expense | 723 Thousand | 139 Thousand | 79 Thousand | 72 Thousand | 6000.00 |
Earnings before Tax | -17.19 Million | 1.1 Million | 838 Thousand | -8.7 Million | 2.17 Million |
Net Income | -17.92 Million | 963 Thousand | 759 Thousand | -8.77 Million | 2.17 Million |
Earnings Per Share Basic | -3.77 | 0.20 | 0.16 | -1.85 | 0.46 |
Earnings Per Share Diluted | -3.77 | 0.20 | 0.16 | -1.85 | 0.46 |
Weighted Average Shares Outstanding | 4.75 Million | 4.81 Million | 4.75 Million | 4.75 Million | 4.73 Million |
Weighted Average Shares Outstanding (Diluted) | 4.75 Million | 4.81 Million | 4.75 Million | 4.75 Million | 4.73 Million |
Gross Margin | 0.84 | 0.82 | 0.20 | 0.73 | 1.00 |
EBIT Margin | 0.34 | 0.15 | -3.99 | 2.48 | -0.56 |
Profit Margin | -5.29 | 0.29 | 1.33 | -5.18 | 0.54 |
EBITDA | 1.14 Million | 249 Thousand | -2.03 Million | -2.25 Million | -2.23 Million |
Earnings Before Tax Margin | - | 0.15 | -4.00 | 2.47 | -0.56 |
Breakdown | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 |
---|---|---|---|---|---|---|
Revenue | 890 Thousand | 3.38 Million | 893 Thousand | 907 Thousand | 926 Thousand | 660 Thousand |
Cost of Revenue | 132 Thousand | 665 Thousand | 250 Thousand | 151 Thousand | 132 Thousand | 132 Thousand |
Gross Profit | 758 Thousand | 2.72 Million | 643 Thousand | 756 Thousand | 794 Thousand | 528 Thousand |
Operating Expenses | 479 Thousand | 1.63 Million | 590 Thousand | 352 Thousand | 335 Thousand | 357 Thousand |
Selling, General and Administrative Expenses | 132 Thousand | - | 621 Thousand | 151 Thousand | 132 Thousand | 132 Thousand |
Research and Development Expenses | - | - | - | - | - | - |
Other Expenses | 479 Thousand | - | - | - | - | - |
Cost and Expenses | 611 Thousand | 2.3 Million | 840 Thousand | 503 Thousand | 467 Thousand | 489 Thousand |
Operating Income | 279 Thousand | 19.38 Million | 19.61 Million | -26 Thousand | -311 Thousand | 102 Thousand |
Interest Expense | - | - | - | - | - | - |
Income Tax Expense | 123 Thousand | 723 Thousand | 350 Thousand | 129 Thousand | 218 Thousand | 26 Thousand |
Earnings before Tax | 319 Thousand | -17.19 Million | -19.51 Million | 834 Thousand | 1.23 Million | 241 Thousand |
Net Income | 197 Thousand | -17.92 Million | -19.86 Million | 705 Thousand | 1.01 Million | 215 Thousand |
Earnings Per Share Basic | 0.04 | - | -4.18 | 0.15 | 0.21 | 0.05 |
Earnings Per Share Diluted | 0.04 | - | -4.18 | 0.15 | 0.21 | 0.05 |
Weighted Average Shares Outstanding | 4.92 Million | 4.75 Million | 4.75 Million | 4.7 Million | 4.85 Million | 4.3 Million |
Weighted Average Shares Outstanding (Diluted) | 4.92 Million | 4.75 Million | 4.75 Million | 4.7 Million | 4.85 Million | 4.3 Million |
Gross Margin | 0.85 | 0.80 | 0.72 | 0.83 | 0.86 | 0.80 |
EBIT Margin | 0.33 | - | 21.98 | -0.02 | -0.32 | 0.17 |
Profit Margin | 0.22 | -5.29 | -22.24 | 0.78 | 1.10 | 0.33 |
EBITDA | 291 Thousand | - | 19.63 Million | -14 Thousand | -299 Thousand | 114 Thousand |
Earnings Before Tax Margin | 0.31 | 5.72 | 21.97 | -0.03 | -0.34 | 0.15 |
JZCP
IMTL
300299
MLNOV
KREBSBIO
002688